Table 2.
Correlation with clinic-pathological features and presence of distant metastasis at the diagnosis.
| Total (59) | M1 (10) | M0-x (49) | p-value | |
|---|---|---|---|---|
| Gender | 0.03 | |||
| M | 16/59 (27%) | 6/16 (37.5%) | 10/16 (62.5%) | |
| F | 43/59 (73%) | 4/43 (9.3%) | 39/43 (90.7%) | |
| Age (average) | 14.40 | 12.50 ± 2.75 | 14.89 ± 2.44 | 0.01 |
| Tumor size (median; mm) | 20.0 | 30 | 21 | 0.08 |
| T | 0.0007 | |||
| 1 | 19/59 (21.7%) | 0/19 (0%) | 19/19 (100%) | |
| 2 | 8/59 (13.6%) | 1/8 (12.5%) | 7/8 (87.5%) | |
| 3 | 26/59 (44.1%) | 4/26 (15.4%) | 22/26 (84.6%) | |
| 4 | 6/59 (10.2%) | 5/6 (83.3%) | 1/6 (16.7%) | |
| Extrathyroidal extension | 0.10 | |||
| Yes | 25/59 (42.3%) | 8/25 (32.0%) | 17/25 (68%) | |
| No | 34/59 (57.7%) | 2/34 (5.9%) | 32/34 (94.1%) | |
| Multifocality | 0.13 | |||
| Yes | 25/59 (42.3%) | 7/25 (28%) | 18/25 (72%) | |
| No | 34/59 (57.7%) | 3/34 (8.8%) | 31/34 (91.1%) | |
| Vascular invasion | 0.28 | |||
| Yes | 48/59 (71.2%) | 10/48 (20.8%) | 38/48 (79.2%) | |
| No | 11/59 (6.7%) | 0/11 (0%) | 11/11 (100%) | |
| Lymph nodal metastasis | 0.02 | |||
| N0 and N1a | 30/59 (50.8%) | 2/30 (6.7%) | 28/30 (93.3%) | |
| N1b | 20/59 (33.9%) | 7/20 (35.0%) | 13/20 (65%) | |
| Nx | 9/59 (15.3%) | 1/9 (11.1%) | 8/9 (88.9%) |
F, female; M, male.
Bold values are the statistically significant associations.